Comments
Daiichi Sankyo on Tuesday said that it will leverage Ranbaxy's distribution strengths and relationships with pharmacists across Italy, for the distribution of Daiichi Sankyo products.
To start with, Ranbaxy will exclusively distribute two of Daiichi Sankyo's long established brands — Congescor and Lopresor — to all pharmacies, in the country. These drugs are used extensively by doctors in Italy for the treatment of congestive heart failure and hypertension. As per IMS Health, the total annual retail sales for the two drugs are around 20 million euros.
“The partnership in Italy provides further impetus to the Hybrid Business Model between the two companies by comprehensively addressing doctors and pharmacists in improving the accessibility of drugs, for patients,” said a press release.
Daiichi Sankyo, Italia, through its dedicated team of medical representatives, will continue to take care of the physicians, mainly cardiologists and internists, promoting the two products.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.